McAdam LLC’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-11,768
| Closed | -$489K | – | 369 |
|
|
2024
Q4 | $489K | Buy |
11,768
+562
| +5% | +$23.4K | 0.03% | 207 |
|
|
2024
Q3 | $749K | Buy |
11,206
+131
| +1% | +$8.76K | 0.04% | 155 |
|
|
2024
Q2 | $1.32M | Buy |
11,075
+117
| +1% | +$13.9K | 0.08% | 103 |
|
|
2024
Q1 | $1.17M | Sell |
10,958
-39
| -0.4% | -$4.16K | 0.07% | 107 |
|
|
2023
Q4 | $1.09M | Buy |
10,997
+2,529
| +30% | +$252K | 0.08% | 102 |
|
|
2023
Q3 | $875K | Buy |
8,468
+562
| +7% | +$58K | 0.07% | 117 |
|
|
2023
Q2 | $961K | Buy |
7,906
+1,092
| +16% | +$133K | 0.08% | 112 |
|
|
2023
Q1 | $1.05M | Buy |
6,814
+3,094
| +83% | +$475K | 0.09% | 108 |
|
|
2022
Q4 | $945K | Sell |
3,720
-1,399
| -27% | -$355K | 0.09% | 79 |
|
|
2022
Q3 | $605K | Buy |
5,119
+754
| +17% | +$89.1K | 0.07% | 120 |
|
|
2022
Q2 | $624K | Buy |
4,365
+159
| +4% | +$22.7K | 0.07% | 122 |
|
|
2022
Q1 | $725K | Buy |
4,206
+486
| +13% | +$83.8K | 0.07% | 94 |
|
|
2021
Q4 | $945K | Buy |
3,720
+1,336
| +56% | +$339K | 0.09% | 79 |
|
|
2021
Q3 | $918K | Sell |
2,384
-22
| -0.9% | -$8.47K | 0.1% | 76 |
|
|
2021
Q2 | $832K | Buy |
2,406
+106
| +5% | +$36.7K | 0.09% | 76 |
|
|
2021
Q1 | $301K | Buy |
+2,300
| New | +$301K | 0.04% | 120 |
|